Journal articleCell Metab2019
Macrophage-Released Pyrimidines Inhibit Gemcitabine Therapy in Pancreatic Cancer.
- Journal
- Cell Metab
- Published
- 28 February 2019
- Citations
- 360
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 6
- Targeting Epithelial-Immune Cell Crosstalk to Improve Therapy in Pancreatic Cancer F32CA228328↗
- Linking epigenetic regulation and TGF-β signaling in pancreatic cancer K08CA234222↗
- Mechanisms of Pancreatic Inflammation, Tissue Repair and Carcinogenesis R01CA151588↗
- Dosage-Dependent Hedgehog Signaling in Pancreatic Cancer R01CA198074↗
- Targeting the Immunosuppressive Tumor Microenvironment in Pancreatic Cancer R50CA232985↗
- Interrupting Cellular Crosstalk in the Immunosuppressive Microenvironment of Pancreas Cancer U01CA224145↗